Aotine betaherpesvirus 1
Aotine betaherpesvirus 1 is a species of virus in the genus Cytomegalovirus, which is part of the subfamily Betaherpesvirinae within the family Herpesviridae. This virus is known to infect New World monkeys, specifically the owl monkey (genus Aotus), and is a subject of interest in virology due to its similarities and differences with human cytomegalovirus (HCMV).
Virology
Aotine betaherpesvirus 1, like other members of the Cytomegalovirus genus, is characterized by its ability to establish lifelong latent infections in its host. The virus has a large double-stranded DNA genome, which is typical of herpesviruses. Upon infection, the virus can remain dormant within the host cells and reactivate under certain conditions, such as immunosuppression.
The virus is primarily transmitted through bodily fluids, and it can cause a range of symptoms depending on the host's immune status. In immunocompetent hosts, the infection is often asymptomatic, while in immunocompromised individuals, it can lead to more severe disease manifestations.
Pathogenesis
The pathogenesis of Aotine betaherpesvirus 1 involves the initial infection of epithelial cells and subsequent spread to other cell types, including fibroblasts and leukocytes. The virus can evade the host immune response through various mechanisms, such as downregulating major histocompatibility complex (MHC) molecules and producing viral proteins that interfere with immune signaling pathways.
Research and Importance
Studying Aotine betaherpesvirus 1 provides valuable insights into the biology of cytomegaloviruses and their interactions with the host immune system. Research on this virus can help in understanding the mechanisms of viral latency, reactivation, and immune evasion, which are critical for developing therapeutic strategies against HCMV and other related viruses.
Also see
Herpesviridae | |
---|---|
![]() | |
Herpesviridae virion | |
Taxonomy | |
Kingdom | Virus |
Order | Herpesvirales |
Family | Herpesviridae |
Genera | |
Notable Species | |
| |
Related Topics | |
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD